Ma Yunbei, Zhou Xiao-Hua
1 School of Statistics, Southwestern University of Finance and Economics, Chengdu, Sichuan, China.
2 HSR&D Center of Excellence, VA Puget Sound Health Care System, Department of Biostatistics, University of Washington, Seattle, USA.
Stat Methods Med Res. 2017 Feb;26(1):124-141. doi: 10.1177/0962280214541724. Epub 2016 Sep 30.
For time-to-event data in a randomized clinical trial, we proposed two new methods for selecting an optimal treatment for a patient based on the covariate-specific treatment effect curve, which is used to represent the clinical utility of a predictive biomarker. To select an optimal treatment for a patient with a specific biomarker value, we proposed pointwise confidence intervals for each covariate-specific treatment effect curve and the difference between covariate-specific treatment effect curves of two treatments. Furthermore, to select an optimal treatment for a future biomarker-defined subpopulation of patients, we proposed confidence bands for each covariate-specific treatment effect curve and the difference between each pair of covariate-specific treatment effect curve over a fixed interval of biomarker values. We constructed the confidence bands based on a resampling technique. We also conducted simulation studies to evaluate finite-sample properties of the proposed estimation methods. Finally, we illustrated the application of the proposed method in a real-world data set.
对于随机临床试验中的生存时间数据,我们基于协变量特定治疗效果曲线提出了两种为患者选择最佳治疗方案的新方法,该曲线用于表示预测生物标志物的临床效用。为了为具有特定生物标志物值的患者选择最佳治疗方案,我们为每条协变量特定治疗效果曲线以及两种治疗的协变量特定治疗效果曲线之间的差异提出了逐点置信区间。此外,为了为未来由生物标志物定义的患者亚组选择最佳治疗方案,我们为每条协变量特定治疗效果曲线以及在生物标志物值的固定区间内每对协变量特定治疗效果曲线之间的差异提出了置信带。我们基于重采样技术构建了置信带。我们还进行了模拟研究,以评估所提出估计方法的有限样本性质。最后,我们说明了所提出方法在一个真实数据集上的应用。